DNX-2401 employs an RGD peptide-modified fibronectin to facilitate viral entry through αvβ3/αvβ5 integrins, effectively bypassing the need for CAR receptors in tumor cells (34, 35). This evidence concerns the gene FN1 and neoplasm.